beta-D-Galp-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Term ID

CHEBI:62158

Synonyms

2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-[beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-alpha-D-galactopyranose
alpha-D-galactopyranose, O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)-2-(acetylamino)-2-deoxy-
beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-alpha-D-GalNAc
Galbeta1-3(GlcNAcbeta1-6)GalNAcalpha
GlcNAcb1-6(Galb1-3)GalNAca
GlcNAcbeta1-6(Galbeta1-3)GalNAcalpha
O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->6)-O-[beta-D-galactopyranosyl-(1->3)]-2-(acetylamino)-2-deoxy-alpha-D-galactopyranose

Definition

The trisaccharide β-D-Gal-(1→3)-[β-D-GlcNAc-(1→6)]-D-GalNAc with α configuration at the anomeric centre of the N-acetylglucosamine residue at the reducing end.

References

glygen:G00033MO
glytoucan:G00033MO
pubmed:19443021
pubmed:21402433
pubmed:25568069
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Phenotype where environments contain beta-D-Galp-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Phenotype modified by environments containing beta-D-Galp-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Phenotype affecting beta-D-Galp-(1->3)-[beta-D-GlcpNAc-(1->6)]-alpha-D-GalpNAc

Human Disease Model